Senior insider sale
Chief Operating Officer at X4 PHARMACEUTICALS, INC — senior position signals high conviction
$4.4K
2.18K shares
What this filing means
DIBIASE MARY plans to sell 2.18K shares of X4 PHARMACEUTICALS, INC valued at approximately $4.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/30/2023ACC: 0001973141-23-000116
Officer· Chief Operating Officer
Since Sep 2021
2.18K
Shares to sell
$4.4K
Approx. market value
464.00
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Stock Award
N/A
6/30/2023
464.00Total acquired464.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/30/2023 | Stock Award N/A | 464.00 | — |
| Total | 464.00 | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
857.00
Market value
$1.7K
6/23/2023
—Completed
Units to sell
857.00
Market value
$1.9K
6/15/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
464.00
Market value
$878.31
6/30/2023
Total
Units
2.18K
Value
$4.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/23/2023 | 857.00 | $1.7K | — | Completed |
6/15/2023 | 857.00 | $1.9K | — | Completed |
| Planned — Approximate Date | ||||
6/30/2023 | 464.00 | $878.31 | NASDAQ | Planned |
| Total | 2.18K | $4.4K | ||